DarkHorse Podcast cover image

#176: Rigging the Game (Bret Weinstein & Heather Heying DarkHorse Livestream)

DarkHorse Podcast

00:00

The FDA's Approval of Recarbio Antibiotic

FDA scientists said that they couldn't draw any inferences for the clinical trials for a new combination antibiotic from Merck. The FDA approved recarbio, but the agency approved it anyway. Recarbio is 40 times more expensive than an existing generic alternative. It's not even totally clear because they're not doing superiority trials.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app